A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancer.
Clin Cancer Res
; 20(19): 5009-22, 2014 Oct 01.
Article
in En
| MEDLINE
| ID: mdl-25124688
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Vaccinia virus
/
Herpesvirus 4, Human
/
Cancer Vaccines
/
Epstein-Barr Virus Nuclear Antigens
/
Epstein-Barr Virus Infections
/
Neoplasms
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2014
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
United States